After nearly a year, venture capitalists nabbed their first U.S. acquisition for more than a billion dollars. And it wasn’t a tech startup. Nor was it a company on the list of known unicorns. And it had nothing to do with blockchain.
Accelerate Baltimore™ is an initiative of the ETC (Emerging Technology Centers), Baltimore’s award winning incubator, and The Abell Foundation. In its first six years, we have invested $1,025,000 in 34 companies. We are now in our seventh year with 6 innovative technology startup companies who are working to accelerate their ideas to market.
Our goal is to close the gap between innovative ideas and getting to market by providing seed capital, resources, mentors, potential partners and a collaborative community. Accelerate Baltimore runs once a year, will you be ready for our next cohort?
Paragon Bioservices (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces the expansion of a new process development and cGMP manufacturing facility located conveniently near Baltimore/Washington International Thurgood Marshall (BWI) Airport. Growing need for broad gene therapy manufacturing capacity from its current and future client base is driving the company’s investment in this new facility, which the company expects will include commercial manufacturing capabilities in 18 to 24 months.
Analysts had forecast a blockbuster year for life science mergers and acquisitions as the lower tax rate for repatriated cash kicks-in and Big Pharma continues its hunt for late-stage assets.
The Association of the British Pharmaceutical Industry has released a report suggesting that pharma companies investing in emerging start-ups is now a key source of capital for biotech innovation in the UK.
Maryland Senate President Thomas V. Mike Miller Jr. (D-Calvert) and Democrats from Montgomery County are rallying around Republican Gov. Larry Hogan’s $5 billion incentive package to lure Amazon.com and a 50,000-person headquarters to the Washington suburb, but it remains to be seen whether the rest of the Democratic-majority legislature will support the package.
2018 SBIR and STTR Omnibus/Parent Grant Solicitations for the NIH, CDC, and FDA, Clinical Trial Not Allowed and Clinical Trial Required
- SBIR Omnibus/Parent Clinical Trial Not Allowed Funding Opportunity Announcement (PA-18-574)
- STTR Omnibus/Parent Clinical Trial Not Allowed Funding Opportunity Announcement (PA-18-575)
- SBIR Omnibus/Parent Clinical Trial Required Funding Opportunity Announcement (PA-18-573)
- STTR Omnibus/Parent Clinical Trial Required Funding Opportunity Announcement (PA-18-576)
New developments in traumatic brain injury prevention, diagnosis and treatment are certain to improve patient health among Soldiers, as well as improve Army readiness, said Tracie Lattimore, director of the Army’s Traumatic Brain Injury program within the Office of the Army Surgeon General.
Thinking you want to make a move to an innovative new tech hub that’s on the front line when it comes to education, research and business development? Forget the expected enclaves of cool like San Francisco or Brooklyn. In-the-know millennials have already moved on to the next innovation hubs.
Six months after closing its most recent funding, Protenus reported raising $11 million in Series B funding, and is planning more hiring.